{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:23:02Z","timestamp":1751430182849,"version":"3.41.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Melorheostosis is a rare skeletal and connective tissue disorder with the estimated prevalence of 1\/1,100,000. Low prevalence of rare diseases (RDs) can lead to suboptimal knowledge and expertise among clinicians.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The European Registries for Rare Endocrine and Bone Conditions (EuRREB) facilitates collection of a set of Core Data Elements and a specific dataset within the \u2018condition specific module\u2019 of the Core Registry platform. The Rare Bone Disease Action Group of the European Calcified Tissue Society (ECTS) collaborated with ERN BOND to develop a specific dataset for Melorheostosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>An initial dataset was shortened to 44 unique variables. In January 2023, the Melorheostosis condition specific module was published and now consists of 18 patients from 2 countries. The median age of patients was 49\u00a0years old (range 23\u201382) and female to male ratio was 15:3 (83.3%). Family history of Melorheostosis was negative for all patients. The most affected bones were lower limbs in 12 cases (66.7%). Specifically, spine, feet and ribs were involved each in 2 cases (11%), skull and pelvis\u2014in one patient each (5.5%). Two patients (11%) suffered from more than 1 lesion. Hyperostosis was present in 3 patients (16.7%), skeletal deformity\u2014in 6 (33%), joint stiffness \u2013 in 11 (61%), asymmetry\u2013in 16 (88.9%), joint limitation\u2013in 12 (66.7%) patients. Swelling and muscle atrophy were reported in 1 case each (5.5%), vascular abnormalities\u2014in 2 cases (11%), skin abnormality in 1 case (5.5%). Pain was present in 14 from 18 patients (77.8%). Genetic testing was performed in 5 patients (27.7%). <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>A condition specific module, for Melorheostosis, within an established registry has been developed. This will serve a useful resource to inform clinicians about this rare disease, and can support several healthcare initiatives such as guidelines creation and healthcare improvement strategies. <\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03862-6","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T20:35:24Z","timestamp":1751402124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Developing a standard dataset in the European registries for rare endocrine and bone conditions\u2014a Melorheostosis dataset"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5035-127X","authenticated-orcid":false,"given":"Natasha M.","family":"Appelman-Dijkstra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariya","family":"Cherenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gavin P. R.","family":"Clunie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Funck-Brentano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinna","family":"Grasemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adalbert","family":"Raimann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem F.","family":"Lems","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Cohen-Solal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"3862_CR1","unstructured":"European Union. Regulation (EC) N\u00b0141\/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products. 2000. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX:32000R0141"},{"issue":"2","key":"3862_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41431-019-0508-0","volume":"28","author":"SN Wakap","year":"2019","unstructured":"Wakap SN, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, Murphy D, Cam YL, Rath A. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2019;28(2):165\u201373. https:\/\/doi.org\/10.1038\/s41431-019-0508-0.","journal-title":"Eur J Hum Genet"},{"key":"3862_CR3","doi-asserted-by":"publisher","unstructured":"Registries for Evaluating Patient Outcomes: A User\u2019s Guide. (2020). https:\/\/doi.org\/10.23970\/ahrqepcregistries4","DOI":"10.23970\/ahrqepcregistries4"},{"key":"3862_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13023-017-0676-3","volume":"12","author":"V H\u00e9on-Klin","year":"2017","unstructured":"H\u00e9on-Klin V. European reference networks for rare diseases: what is the conceptual framework? Orphanet J Rare Dis. 2017;12:137. https:\/\/doi.org\/10.1186\/s13023-017-0676-3.","journal-title":"Orphanet J Rare Dis"},{"key":"3862_CR5","doi-asserted-by":"publisher","first-page":"104916","DOI":"10.1016\/j.ejmg.2024.104916","volume":"68","author":"L Casareto","year":"2024","unstructured":"Casareto L, Appelman-Dijkstra NM, Brandi ML, Chapurlat R, Cormier-Daire V, Hamdy NAT, Heath KE, Horn J, Mantovani G, Mohnike K, Sousa SB, Travessa A, Wekre LL, Zillikens MC, Sangiorgi L. ERN BOND: The key European network leveraging diagnosis, research, and treatment for rare bone conditions. Eur J Med Genet. 2024;68:104916. https:\/\/doi.org\/10.1016\/j.ejmg.2024.104916.","journal-title":"Eur J Med Genet"},{"key":"3862_CR6","unstructured":"Orphanet: Melorheostosis. https:\/\/www.orpha.net\/en\/disease\/detail\/2485?name=Melorheostosis&mode=name"},{"key":"3862_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03720-z","author":"H Kang","year":"2018","unstructured":"Kang H, Jha S, Deng Z, Fratzl-Zelman N, Cabral WA, Ivovic A, Meylan F, Hanson EP, Lange E, Katz J, Roschger P, Klaushofer K, Cowen EW, Siegel RM, Marini JC, Bhattacharyya T. Somatic activating mutations in MAP2K1 cause melorheostosis. Nat Commun. 2018. https:\/\/doi.org\/10.1038\/s41467-018-03720-z.","journal-title":"Nat Commun"},{"key":"3862_CR8","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191499","author":"H Kang","year":"2020","unstructured":"Kang H, Jha S, Ivovic A, Fratzl-Zelman N, Deng Z, Mitra A, Cabral WA, Hanson EP, Lange E, Cowen EW, Katz J, Roschger P, Klaushofer K, Dale RK, Siegel RM, Bhattacharyya T, Marini JC. Somatic SMAD3-activating mutations cause melorheostosis by up-regulating the TGF-\u03b2\/SMAD pathway. J Exp Med. 2020. https:\/\/doi.org\/10.1084\/jem.20191499.","journal-title":"J Exp Med"},{"key":"3862_CR9","doi-asserted-by":"publisher","unstructured":"Iordache S, Cursaru A, Serban B, Costache M, Spiridonica R, Cretu B, Cirstoiu C.(2023, April 30). Melorheostosis: A Review of the Literature and a Case Report. Medicina. https:\/\/doi.org\/10.3390\/medicina59050869","DOI":"10.3390\/medicina59050869"},{"issue":"3","key":"3862_CR10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.pmrj.2016.07.530","volume":"9","author":"GC Smith","year":"2016","unstructured":"Smith GC, Pingree MJ, Freeman LA, Matsumoto JM, Howe BM, Kannas SN, Pyfferoen MD, Struss LT, Wenger DE, Amrami KK, Matsumoto M, Jurisson ML. Melorheostosis: a retrospective clinical analysis of 24 patients at the mayo clinic. PM&R. 2016;9(3):283\u20138. https:\/\/doi.org\/10.1016\/j.pmrj.2016.07.530.","journal-title":"PM&R"},{"key":"3862_CR11","doi-asserted-by":"publisher","DOI":"10.4081\/reumatismo.2024.1621","author":"M Ruggiero","year":"2024","unstructured":"Ruggiero M, Conforti A, Culcasi A, Mazzanti C, Sibahi G, Rani N, Sartini S. A focus on melorheostosis disease: a literature review and case report of femoral-acetabular impingement due to melorheostosis treated with surgical hip osteoplasty. Reumatismo. 2024. https:\/\/doi.org\/10.4081\/reumatismo.2024.1621.","journal-title":"Reumatismo"},{"issue":"2","key":"3862_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00223-019-00565-6","volume":"105","author":"M Gnoli","year":"2019","unstructured":"Gnoli M, Staals EL, Campanacci L, Bedeschi MF, Faletra F, Gallone S, Gaudio A, Mattina T, Gurrieri F, Percesepe A, Neri I, Virdi A, Tremosini M, Milanesi A, Brizola E, Pedrini E, Sangiorgi L. Melorheostosis and osteopoikilosis clinical and molecular description of an italian case series. Calcif Tissue Int. 2019;105(2):215\u201321. https:\/\/doi.org\/10.1007\/s00223-019-00565-6.","journal-title":"Calcif Tissue Int"},{"key":"3862_CR13","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.crad.2010.02.004","volume":"65","author":"S Suresh","year":"2010","unstructured":"Suresh S, Muthukumar T, Saifuddin A. Classical and unusual imaging appearances of melorheostosis. Clin Radiol. 2010;65:593\u2013600. https:\/\/doi.org\/10.1016\/j.crad.2010.02.004.","journal-title":"Clin Radiol"},{"issue":"1","key":"3862_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/jbmr.3577","volume":"34","author":"S Jha","year":"2018","unstructured":"Jha S, Fratzl-Zelman N, Roschger P, Papadakis GZ, Cowen EW, Kang H, Lehky TJ, Alter K, Deng Z, Ivovic A, Flynn L, Reynolds JC, Dasgupta A, Miettinen M, Lange E, Katz J, Klaushofer K, Marini JC, Siegel RM, Bhattacharyya T. Distinct clinical and pathological features of melorheostosis associated With somatic MAP2K1 mutations. J Bone Miner Res. 2018;34(1):145\u201356. https:\/\/doi.org\/10.1002\/jbmr.3577.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"3862_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/rhu.0b013e3181d0ffe3","volume":"16","author":"M Saghafi","year":"2010","unstructured":"Saghafi M, Sahebari M, Goshayeshi L. Linear scleroderma in association with melorheostosis. J Clin Rheumatol. 2010;16(2):99\u2013100. https:\/\/doi.org\/10.1097\/rhu.0b013e3181d0ffe3.","journal-title":"J Clin Rheumatol"},{"key":"3862_CR16","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s12020-021-02617-0","volume":"71","author":"SR Ali","year":"2021","unstructured":"Ali SR, Bryce J, Smythe C, Hytiris M, Priego AL, Appelman-Dijkstra NM, Ahmed SF. Supporting international networks through platforms for standardised data collection\u2014the European Registries for Rare Endocrine Conditions (EuRRECa) model. Endocrine. 2021;71:555\u201360. https:\/\/doi.org\/10.1007\/s12020-021-02617-0.","journal-title":"Endocrine"},{"issue":"2","key":"3862_CR17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4103\/0973-1075.84531","volume":"17","author":"SP Kumar","year":"2011","unstructured":"Kumar SP. Utilization of brief pain inventory as an assessment tool for pain in patients with cancer: a focused review. Indian J Palliat Care. 2011;17(2):108. https:\/\/doi.org\/10.4103\/0973-1075.84531.","journal-title":"Indian J Palliat Care"},{"issue":"5","key":"3862_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/00002508-200409000-00005","volume":"20","author":"S Keller","year":"2004","unstructured":"Keller S, Bann CM, Dodd SL, Schein J, Mendoza TR, Cleeland CS. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain. 2004;20(5):309\u201318. https:\/\/doi.org\/10.1097\/00002508-200409000-00005.","journal-title":"Clin J Pain"},{"issue":"4","key":"3862_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ejpain.2005.06.002","volume":"10","author":"T Mendoza","year":"2006","unstructured":"Mendoza T, Mayne T, Rublee D, Cleeland C. Reliability and validity of a modified Brief Pain Inventory short form in patients with osteoarthritis. Eur J Pain. 2006;10(4):353. https:\/\/doi.org\/10.1016\/j.ejpain.2005.06.002.","journal-title":"Eur J Pain"},{"key":"3862_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01857-7","author":"H Anttila","year":"2021","unstructured":"Anttila H, Tallqvist S, Mu\u00f1oz M, Lepp\u00e4joki-Tiistola S, M\u00e4kitie O, Hiekkala S. Towards an ICF-based self-report questionnaire for people with skeletal dysplasia to study health, functioning, disability and accessibility. Orphanet J Rare Dis. 2021. https:\/\/doi.org\/10.1186\/s13023-021-01857-7.","journal-title":"Orphanet J Rare Dis"},{"key":"3862_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-020-03835-9","author":"H Hyv\u00f6nen","year":"2020","unstructured":"Hyv\u00f6nen H, Anttila H, Tallqvist S, Mu\u00f1oz M, Lepp\u00e4joki-Tiistola S, Teittinen A, M\u00e4kitie O, Hiekkala S. Functioning and equality according to international classification of functioning, disability and health (ICF) in people with skeletal dysplasia compared to matched control subjects \u2013 a cross-sectional survey study. BMC Musculoskelet Disord. 2020. https:\/\/doi.org\/10.1186\/s12891-020-03835-9.","journal-title":"BMC Musculoskelet Disord"},{"issue":"8","key":"3862_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012331","volume":"6","author":"JC Hill","year":"2016","unstructured":"Hill JC, Kang S, Benedetto E, Myers H, Blackburn S, Smith S, Dunn KM, Hay E, Rees J, Beard D, Glyn-Jones S, Barker K, Ellis B, Fitzpatrick R, Price A. Development and initial cohort validation of the Arthritis Research UK Musculoskeletal Health Questionnaire (MSK-HQ) for use across musculoskeletal care pathways. BMJ Open. 2016;6(8): e012331. https:\/\/doi.org\/10.1136\/bmjopen-2016-012331.","journal-title":"BMJ Open"},{"issue":"2","key":"3862_CR23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0304-3959(76)90113-5","volume":"2","author":"J Scott","year":"1976","unstructured":"Scott J, Huskisson EC. Graphic representation of pain. Pain. 1976;2(2):175\u201384. https:\/\/doi.org\/10.1016\/0304-3959(76)90113-5.","journal-title":"Pain"},{"issue":"2","key":"3862_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0304-3959(90)90018-9","volume":"41","author":"D Bieri","year":"1990","unstructured":"Bieri D, Reeve RA, Champion DG, Addicoat L, Ziegler JB. The faces pain scale for the self-assessment of the severity of pain experienced by children: Development, initial validation, and preliminary investigation for ratio scale properties. Pain. 1990;41(2):139\u201350. https:\/\/doi.org\/10.1016\/0304-3959(90)90018-9.","journal-title":"Pain"},{"key":"3862_CR25","doi-asserted-by":"publisher","DOI":"10.1159\/000533763","author":"SC Chen","year":"2023","unstructured":"Chen SC, Bryce J, Chen M, Charmandari E, Choi JH, Dou X, Gong C, Hamza R, Harvey J, Hoffman AR, Horikawa R, Johannson G, Jorge AADL, Miller BS, Roehrich S, S\u00e4vendahl L, Tseretopoulou X, Vitali D, Wajnrajch M, Ahmed S. Development of a minimum dataset for the monitoring of recombinant human growth hormone therapy in children with growth hormone deficiency: A GloBE-Reg initiative. Hormone Res Paediatr. 2023. https:\/\/doi.org\/10.1159\/000533763.","journal-title":"Hormone Res Paediatr"},{"issue":"12","key":"3862_CR26","doi-asserted-by":"publisher","first-page":"104868","DOI":"10.1016\/j.ejmg.2023.104868","volume":"66","author":"ALP Zurita","year":"2023","unstructured":"Zurita ALP, Grasemann C, Boarini M, Chapurlat R, Mordenti M, Javaid MK, Appelman-Dijkstra NM. Data collection on rare bone and mineral conditions in Europe: The landscape of registries and databases. Eur J Med Genet. 2023;66(12):104868. https:\/\/doi.org\/10.1016\/j.ejmg.2023.104868.","journal-title":"Eur J Med Genet"},{"key":"3862_CR27","doi-asserted-by":"crossref","unstructured":"Mack C, Su Z, Westreich D. (2018). Managing missing data in patient registries: addendum to registries for evaluating patient outcomes: A User\u2019s Guide, Third Edition. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK493611\/","DOI":"10.23970\/AHRQREGISTRIESMISSINGDATA"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03862-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03862-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03862-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T20:35:25Z","timestamp":1751402125000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03862-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3862"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03862-6","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"4 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The project complies with EU GDPR and was approved by the Information Governance authorities at the NHS Greater Glasgow & Clyde Health Board and the National Research Ethics Service in the UK (e-REC REC Reference 17\/WS\/0178; Core Registry REC Reference 18\/\/WS\/0205), and later at the Leiden University Medical Center (e-REC project ID 133036; Core Registry protocol nWMODIV2_2024018, project ID 130850). Informed written consent was obtained from all individual participants in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NMA-D: ECTS Rare bone Disease Action Group member, EuRREB coordinator and ERN BOND HCP representative, (ERN BOND and EuRR-Bone are funded by the European Union, project 101157116 (ERN BOND); within the framework of the EU4Health Programme 2021\u20132027.)","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"331"}}